| Market Cap | $1.44B+132.8% |
| Revenue (ttm) | $123.25M |
| Net Income | -$53.69M |
| EPS | -$0.21 |
| Shares Out | 246.03M |
| PE Ratio | n/a |
| Forward PE | -83.08 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 4,107,411 |
| Open | $5.68 |
| Previous Close | $5.85 |
| Day's Range | $5.34 - $5.78 |
| 52-Week Range | $2.69 - $10.21 |
| Beta | 2.12 |
| Analysts | none |
| Price Target | $11.17(+106.79%) |
| Earnings Date | Oct 29, 2026 |
About BFLY
Butterfly Network, Inc. develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. The company offers Butterfly iQ+ and iQ3 ultrasound devices that can perform whole-body imaging on a single handheld probe integrated with the clinical workflow, and accessible on a user's smartphone, tablet, and almost any hospital computer system; Butterfly Move, merging the mobility of a handheld with the stability of a full cart system; and iQ+ Bladder, a specialty product for bladder scanning market. It also provides Compass AI which offers one system to connect every device, workflow, and department; ScanLab, an AI-powered educational platform that provides written walkthroughs and reference imagery to guide real-time educational scanning; and Butterfly iQ+/iQ3 Vet, a third generation handheld ultrasound system. It sells and markets its products through a direct sales force, distributors, and e-commerce channels. Butterfly Network, Inc. was founded in 2011 and is headquartered in Burlington, Massachusetts.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
Analyst consensus
1 firm rating BFLY in the last 3 months, one vote each. Issuer-paid research is not counted.
$BFLY stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in BFLY holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by BFLY's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
BFLY Estimated quarterly lobbying spending
Source: U.S. Senate LDA
BFLY Revenue by Segment or Geography
| Core business | $21.51M | 32.99% |
| Software and other services | $16.97M | 26.03% |
| Product | $15.63M | 23.97% |
| Embedded | $11.09M | 17.01% |
As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New BFLY patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to BFLY from public contracts
Source: USAspending.gov
Bull Case vs Bear Case
AI-generated from BFLY’s recent data — informational, not investment advice
What’s Behind the Score
News check: Raised guidance and CEO commentary on chip revenue growth offset by insider selling; overall constructive business momentum.
Recent Insider Activity
Insider Score Trend Over Time
+17.1 since Sep 13Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.
Frequently Asked Questions
ETFs that hold this stock
| ARKG | ARK Genomic Revolution ETF | 1.82% |
| XHE | State Street SPDR S&P Health Care Equipment ETF | 1.36% |
| SPXZ | Morgan Creek - Exos SPAC Originated ETF | 1.22% |
| HYP | Golden Eagle Dynamic Hypergrowth ETF | 1.22% |
| HEAL | Global X HealthTech ETF | 1.14% |
| MOON | Direxion Moonshot Innovators ETF | 1.14% |
| EKG | First Trust Nasdaq Lux Digital Health Solutions ETF | 0.47% |
| CTAG | Calamos Timpani Active SMID Growth ETF | 0.46% |
| FYC | First Trust Small Cap Growth AlphaDEX Fund | 0.44% |
| IWC | iShares Micro-Cap ETF | 0.39% |
| AESB | Harbor AlphaEdge Small Cap Core ETF | 0.32% |
| AESG | Harbor AlphaEdge Small Cap Growth ETF | 0.31% |
Weight is the stock’s share of each fund’s holdings.
